Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome - PubMed (original) (raw)
Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome
Eva-Maria Rüth et al. J Pediatr. 2005 Aug.
Abstract
Objective: Long-term outcome of steroid-sensitive idiopathic nephrotic syndrome (SSNS) in children is usually considered benign, although data on follow-up into adulthood are scarce. The aim of this study was to investigate adults who had childhood SSNS regarding their relapse rate, growth, and renal and extrarenal morbidity.
Study design: Adult patients (n=42, 26 males) were evaluated at a median age of 28.0 (18.1 to 46.9) years and a median follow-up of 22.0 (2.9 to 39.0) years since diagnosis.
Results: Fourteen of 42 (33%) patients relapsed in adulthood. The number of relapses during childhood and adolescence and a complicated course-administration of steroid-sparing medication such as cyclophosphamide, chlorambucil, and cyclosporin A-were identified as risk factors. Final adult height (median SD score -0.4, range -3.3 to +1.3) and body mass index (BMI) were normal. Renal function was normal in all patients, and overall morbidity was low. Only eight patients (three males) had children. Cytotoxic therapy was identified as a major factor contributing to childlessness.
Conclusion: Relapses in adulthood were common in pediatric patients with SSNS. Growth and renal function were normal, and overall morbidity was low. Yet, transition to an adult nephrologist is recommended for all children with relapsing SSNS.
Similar articles
- Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M. Skrzypczyk P, et al. Clin Nephrol. 2014 Mar;81(3):166-73. doi: 10.5414/CN108044. Clin Nephrol. 2014. PMID: 24361057 - Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grünfeld JP, Niaudet P. Fakhouri F, et al. Am J Kidney Dis. 2003 Mar;41(3):550-7. doi: 10.1053/ajkd.2003.50116. Am J Kidney Dis. 2003. PMID: 12612977 - Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ. Kemper MJ, et al. Nephrol Dial Transplant. 2004 May;19(5):1136-41. doi: 10.1093/ndt/gfh066. Epub 2004 Feb 19. Nephrol Dial Transplant. 2004. PMID: 14993510 - [Treatment of corticoid-resistant nephrotic syndrome: a still unresolved problem].
Damiani B, Giani M, Consalvo G, Carcano A, Ghio L, Edefonti A. Damiani B, et al. Pediatr Med Chir. 1995 Jan-Feb;17(1):9-15. Pediatr Med Chir. 1995. PMID: 7739938 Review. Italian. - [Nephrotic syndrome in childhood].
Reusz G, Szabó A, Fekete A. Reusz G, et al. Orv Hetil. 2006 Nov 26;147(47):2251-60. Orv Hetil. 2006. PMID: 17380687 Review. Hungarian.
Cited by
- Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome.
Mohamad K, Zainal H, Abdul Rahim NA, Tengku Hussain TH. Mohamad K, et al. J Nephrol. 2024 Sep 1. doi: 10.1007/s40620-024-02076-6. Online ahead of print. J Nephrol. 2024. PMID: 39218996 - Corticosteroid therapy for nephrotic syndrome in children.
Hahn D, Samuel SM, Willis NS, Craig JC, Hodson EM. Hahn D, et al. Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD001533. doi: 10.1002/14651858.CD001533.pub7. Cochrane Database Syst Rev. 2024. PMID: 39171624 Review. - Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study.
Robinson CH, Aman N, Banh T, Brooke J, Chanchlani R, Dhillon V, Langlois V, Levin L, Licht C, McKay A, Noone D, Parikh A, Pearl R, Radhakrishnan S, Rowley V, Teoh CW, Vasilevska-Ristovska J, Parekh RS. Robinson CH, et al. Pediatr Nephrol. 2024 Sep;39(9):2667-2677. doi: 10.1007/s00467-024-06370-0. Epub 2024 Apr 18. Pediatr Nephrol. 2024. PMID: 38637343 - Traditional Chinese medicine for idiopathic membranous nephropathy: A systematic review and meta-analysis.
Shan W, Guan H, Gu H, Wang R, Huang X, Li P, Xie Y, Bao K, Qin X. Shan W, et al. Heliyon. 2024 Mar 31;10(7):e28836. doi: 10.1016/j.heliyon.2024.e28836. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38596093 Free PMC article. - Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis.
Ji B, Liu J, Yin Y, Xu H, Shen Q, Yu J. Ji B, et al. Cell Death Dis. 2023 Sep 9;14(9):601. doi: 10.1038/s41419-023-06124-0. Cell Death Dis. 2023. PMID: 37689694 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical